Your browser doesn't support javascript.
loading
Long non-coding RNA MANCR is a target of BET bromodomain protein BRD4 and plays a critical role in cellular migration and invasion abilities of prostate cancer.
Nagasawa, Masayuki; Tomimatsu, Kosuke; Terada, Koji; Kondo, Kenta; Miyazaki, Kazuko; Miyazaki, Masaki; Motooka, Daisuke; Okuzaki, Daisuke; Yoshida, Tetsuya; Kageyama, Susumu; Kawamoto, Hiroshi; Kawauchi, Akihiro; Agata, Yasutoshi.
Afiliação
  • Nagasawa M; Department of Biochemistry and Molecular Biology, Shiga University of Medical Science, Shiga, Japan; Department of Urology, Shiga University of Medical Science, Shiga, Japan.
  • Tomimatsu K; Department of Biochemistry and Molecular Biology, Shiga University of Medical Science, Shiga, Japan.
  • Terada K; Department of Biochemistry and Molecular Biology, Shiga University of Medical Science, Shiga, Japan.
  • Kondo K; Department of Biochemistry and Molecular Biology, Shiga University of Medical Science, Shiga, Japan.
  • Miyazaki K; Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Miyazaki M; Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Motooka D; Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Okuzaki D; Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Yoshida T; Department of Urology, Shiga University of Medical Science, Shiga, Japan.
  • Kageyama S; Department of Urology, Shiga University of Medical Science, Shiga, Japan.
  • Kawamoto H; Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Kawauchi A; Department of Urology, Shiga University of Medical Science, Shiga, Japan.
  • Agata Y; Department of Biochemistry and Molecular Biology, Shiga University of Medical Science, Shiga, Japan. Electronic address: yagata@belle.shiga-med.ac.jp.
Biochem Biophys Res Commun ; 526(1): 128-134, 2020 05 21.
Article em En | MEDLINE | ID: mdl-32199616
ABSTRACT
Androgen receptor (AR)-negative castration-resistant prostate cancer (CRPC) is highly aggressive and is resistant to most of the current therapies. Bromodomain and extra terminal domain (BET) protein BRD4 binds to super-enhancers (SEs) that drive high expression of oncogenes in many cancers. A BET inhibitor, JQ1, has been found to suppress the malignant phenotypes of prostate cancer cells, however, the target genes of JQ1 remain largely unknown. Here we show that SE-associated genes specific for AR-negative CRPC PC3 cells include genes involved in migration and invasion, and that JQ1 impairs migration and invasion of PC3 cells. We identified a long non-coding RNA, MANCR, which was markedly down-regulated by JQ1, and found that BRD4 binds to the MANCR locus. MANCR knockdown led to a significant decrease in migration and invasion of PC3 cells. Furthermore, RNA sequencing analysis revealed that expression of the genes involved in migration and invasion was altered by MANCR knockdown. In summary, our data demonstrate that MANCR plays a critical role in migration and invasion of PC3 cells.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fatores de Transcrição / Movimento Celular / Proteínas de Ciclo Celular / RNA não Traduzido Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fatores de Transcrição / Movimento Celular / Proteínas de Ciclo Celular / RNA não Traduzido Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão